Human genome comparison of paretic and nonparetic vastus lateralis muscle in patients with hemiparetic stroke

Journal of Rehabilitation Research and Development

Volumn 45, Issue 2, 2008, Pages 273-282

  McKenzie, Michael J ^a   Yu, Shuzhen ^a   Macko, Richard F ^a,b   McLenithan, John C ^a   Hafer Macko, Charlene E ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cell cycle; Gene expression; Hemiparetic stroke; Inflammation; Metabolism; Microarray; Muscle contraction; Rehabilitation; Skeletal muscle; Transcription factors; Vastus lateralis

Indexed keywords

CELL CYCLE; HEMIPARETIC STROKE; INFLAMMATION; MUSCLE CONTRACTION; REHABILITATION; SKELETAL MUSCLE; VASTUS LATERALIS;

BIOACTIVITY; BIOCHEMISTRY; GENES; GLUCOSE; LAWS AND LEGISLATION; MEDICAL PROBLEMS; METABOLISM; PATHOLOGY; PATIENT REHABILITATION; SHRINKAGE; SIGNAL TRANSDUCTION; TRANSCRIPTION; TRANSCRIPTION FACTORS;

MUSCLE;

BIOLOGICAL MARKER; CONTRACTILE PROTEIN; MYOSIN HEAVY CHAIN; RNA;

ADULT; AGED; ARTICLE; CELL CYCLE REGULATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC ANALYSIS; GLUCOSE TOLERANCE; HEMIPLEGIA; HUMAN; HUMAN GENOME; HUMAN TISSUE; MALE; MICROARRAY ANALYSIS; MULTIGENE FAMILY; MUSCLE INJURY; MUSCLE METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PARESIS; PREVALENCE; PRIORITY JOURNAL; PUNCH BIOPSY; SIGNAL TRANSDUCTION; STROKE; VASTUS LATERALIS MUSCLE; CELL CYCLE; CHRONIC DISEASE; COMPARATIVE STUDY; GENETIC TRANSCRIPTION; GENETICS; INFLAMMATION; LEG; METABOLISM; MIDDLE AGED; MUSCLE CONTRACTION; PATHOPHYSIOLOGY; SKELETAL MUSCLE;

AGED; AGED, 80 AND OVER; CELL CYCLE; CHRONIC DISEASE; FEMALE; GENE EXPRESSION; HUMANS; INFLAMMATION; LOWER EXTREMITY; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; MUSCLE CONTRACTION; MUSCLE, SKELETAL; PARESIS; RNA; SIGNAL TRANSDUCTION; STROKE; TRANSCRIPTION, GENETIC;

EID: 63249095302     PISSN: 07487711     EISSN: 07487711     Source Type: Journal    
DOI: 10.1682/JRRD.2007.02.0036     Document Type: Article

References (60)

1. Gresham GE, Phillips TF, Wolf PA, McNamara PM, Kannel WB, Dawber TR. Epidemiologic profile of long-term stroke disability: The Framingham study. Arch Phys Med Rehabil. 1979;60(11):487-491
2. Blaak EE. Basic disturbances in skeletal muscle fatty acid metabolism in obesity and type 2 diabetes mellitus. Proc Nutr Soc. 2004;63(2):323-330
3. De Deyne PG, Hafer-Macko CE, Ivey FM, Ryan AS, Macko RF. Muscle molecular phenotype after stroke is associated with gait speed. Muscle Nerve. 2004;30(2):209-215
4. Ivey FM, Ryan AS, Hafer-Macko CE, Garrity BM, Sorkin JD, Goldberg AP, Macko RF. High prevalence of abnormal glucose metabolism and poor sensitivity of fasting plasma glucose in the chronic phase of stroke. Cerebrovasc Dis. 2006;22(5-6):368-371
5. Kernan WN, Inzucchi SE. Type 2 diabetes mellitus and insulin resistance: Stroke prevention and management. Curr Treat Options Neurol. 2004;6(6):443-450
6. Roth EJ. Heart disease in patients with stroke: Incidence, impact, and implications for rehabilitation. Part 1: Classification and prevalence. Arch Phys Med Rehabil. 1993;74(7): 752-760
7. Vermeer SE, Sandee W, Algra A, Koudstaal PJ, Kappelle LJ, Dippel DW; Dutch TIA Trial Study Group. Impaired glucose tolerance increases stroke risk in nondiabetic patients with transient ischemic attack or minor ischemic stroke. Stroke. 2006;37(6):1413-1417
8. Gresham GE, Fitzpatrick TE, Wolf PA, McNamara PM, Kannel WB, Dawber TR. Residual disability in survivors of stroke-The Framingham study. N Engl J Med. 1975; 293(19):954-956
9. U.S. Department of Health and Human Services. Poststroke rehabilitation: Clinical practice guideline number 16. Rockville (MD): Public Health Service, Agency for Health Care Policy and Research; 1995.
10. Wade DT, Hewer RL. Functional abilities after stroke: Measurement, natural history and prognosis. J Neurol Neurosurg Psychiatry. 1987;50(2):177-182
11. Williams GR, Jiang JG, Matchar DB, Samsa GP. Incidence and occurrence of total (first-ever and recurrent) stroke. Stroke. 1999;30(12):2523-2528
12. Landin S, Hagenfeldt L, Saltin B, Wahren J. Muscle metabolism during exercise in hemiparetic patients. Clin Sci Mol Med. 1977;53(3):257-269
13. Daugaard JR, Richter EA. Relationship between muscle fibre composition, glucose transporter protein 4 and exercise training: Possible consequences in non-insulin-dependent diabetes mellitus. Acta Physiol Scand. 2001;171(3):267-276
14. Hafer-Macko CE, Yu S, Ryan AS, Ivey FM, Macko RF. Elevated tumor necrosis factor-alpha in skeletal muscle after stroke. Stroke. 2005;36(9):2021-2023
15. Ryan AS, Dobrovolny CL, Smith GV, Silver KH, Macko RF. Hemiparetic muscle atrophy and increased intramuscular fat in stroke patients. Arch Phys Med Rehabil. 2002; 83(12):1703-1707
16. Burnham R, Martin T, Stein R, Bell G, MacLean I, Steadward R. Skeletal muscle fibre type transformation following spinal cord injury. Spinal Cord. 1997;35(2):86-91.
17. Macko RF, Ivey FM, Forrester LW, Hanley D, Sorkin JD, Katzel LI, Silver KH, Goldberg AP. Treadmill exercise rehabilitation improves ambulatory function and cardiovascular fitness in patients with chronic stroke: A randomized, controlled trial. Stroke. 2005;36(10):2206-2211
18. Haeuber E, Shaughnessy M, Forrester LW, Coleman KL, Macko RF. Accelerometer monitoring of home- and community- based ambulatory activity after stroke. Arch Phys Med Rehabil. 2004;85(12):1997-2001.
19. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162(1):156-159
20. Mayne CN, Sutherland H, Jarvis JC, Gilroy SJ, Craven AJ, Salmons S. Induction of a fast-oxidative phenotype by chronic muscle stimulation: Histochemical and metabolic studies. Am J Physiol. 1996;270(1 Pt 1):C313-20.
21. Gregory CM, Vandenborne K, Dudley GA. Metabolic enzymes and phenotypic expression among human locomotor muscles. Muscle Nerve. 2001;24(3):387-393
22. Mujika I, Padilla S. Muscular characteristics of detraining in humans. Med Sci Sports Exerc. 2001;33(8):1297-1303.
23. Ryan AS, Dobrovolny CL, Smith GV, Silver KH, Macko RF. Cardiovascular fitness after stroke: Role of muscle mass and gait deficit severity. J Stroke Cerebrovasc Dis. 2000;9:1-8.
24. Pette D, Staron RS. Myosin isoforms, muscle fiber types, and transitions. Microsc Res Tech. 2000;50(6):500-509.
25. Serrano AL, Quiroz-Rothe E, Rivero JL. Early and long-term changes of equine skeletal muscle in response to endurance training and detraining. Pflugers Arch. 2000; 441(2-3):263-274
26. Talmadge RJ. Myosin heavy chain isoform expression following reduced neuromuscular activity: Potential regulatory mechanisms. Muscle Nerve. 2000;23(5):661-679
27. Andruchov O, Andruchova O, Wang Y, Galler S. Dependence of cross-bridge kinetics on myosin light chain isoforms in rabbit and rat skeletal muscle fibres. J Physiol. 2006;571(Pt 1):231-242
28. Gonzalez B, Negredo P, Hernando R, Manso R. Protein variants of skeletal muscle regulatory myosin light chain isoforms: Prevalence in mammals, generation and transitions during muscle remodeling. Pflugers Arch. 2002;443(3): 377-386
29. Zawadowska B, Majerczak J, Semik D, Karasinski J, Kolodziejski L, Kilarski WM, Duda K, Zoladz JA. Characteristics of myosin profile in human vastus lateralis muscle in relation to training background. Folia Histochem Cytobiol. 2004;42(3):181-190
30. Shields RK, Dudley-Javoroski S. Musculoskeletal plasticity after acute spinal cord injury: Effects of long-term neuromuscular electrical stimulation training. J Neurophysiol. 2006;95(4):2380-2390
31. Collins CA, Partridge TA. Self-renewal of the adult skeletal muscle satellite cell. Cell Cycle. 2005;4(10):1338-1341
32. Grounds MD, Yablonka-Reuveni Z. Molecular and cell biology of skeletal muscle regeneration. Mol Cell Biol Hum Dis Ser. 1993;3:210-256
33. Fornace AJ Jr, Nebert DW, Hollander MC, Luethy JD, Papathanasiou M, Fargnoli J, Holbrook NJ. Mammalian genes coordinately regulated by growth arrest signals and DNA-damaging agents. Mol Cell Biol. 1989;9(10):4196-4203.
34. Kolodner R. Biochemistry and genetics of eukaryotic mismatch repair. Genes Dev. 1996;10(12):1433-1442
35. Kraus MH, Issing W, Miki T, Popescu NC, Aaronson SA. Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: Evidence for overexpression in a subset of human mammary tumors. Proc Natl Acad Sci U S A. 1989;86(23):9193-9197
36. Tallquist MD, Weismann KE, Hellstrom M, Soriano P. Early myotome specification regulates PDGFA expression and axial skeleton development. Development. 2000;127(23): 5059-5070
37. Bazan NG, Marcheselli VL, Cole-Edwards K. Brain response to injury and neurodegeneration: Endogenous neuroprotective signaling. Ann N Y Acad Sci. 2005;1053: 137-147
38. Hara MR, Snyder SH. Cell signaling and neuronal death. Annu Rev Pharmacol Toxicol. 2007;47:117-141
39. Blobel CP. Metalloprotease-disintegrins: Links to cell adhesion and cleavage of TNF alpha and notch. Cell. 1997; 90(4):589-592
40. Baldwin KM, Herrick RE, McCue SA. Substrate oxidation capacity in rodent skeletal muscle: Effects of exposure to zero gravity. J Appl Physiol. 1993;75(6):2466-2470
41. Dupont-Versteegden EE, Houle JD, Gurley M, Peterson CA. Early changes in muscle fiber size and gene expression in response to spinal cord transection and exercise. Am J Physiol. 1998;275(4 Pt 1):C1124-33.
42. Hutchinson KJ, Linderman JK, Basso DM. Skeletal muscle adaptations following spinal cord contusion injury in rat and the relationship to locomotor function: A time course study. J Neurotrauma. 2001;18(10):1075-1089
43. Stein TP, Wade CE. Metabolic consequences of muscle disuse atrophy. J Nutr. 2005;135(7):1824S-28.
44. Bauman WA, Spungen AM. Metabolic changes in persons after spinal cord injury. Phys Med Rehabil Clin N Am. 2000;11(1):109-140
45. Elder CP, Apple DF, Bickel CS, Meyer RA, Dudley GA. Intramuscular fat and glucose tolerance after spinal cord injury - A cross-sectional study. Spinal Cord. 2004;42(12): 711-716
46. Urso ML, Chen YW, Scrimgerour AG, Lee PC, Lee KF, Clarkson PM. Alterations in mRNA expression and protein products following spinal cord injury in humans. J Appl Physiol. 2007;579(Pt 3):877-892
47. Urso ML, Scrimgeour AG, Chen YW, Thompson PD, Clarkson PM. Analysis of human skeletal muscle after 48 h immobilization reveals alterations in mRNA and protein for extracellular matrix components. J Appl Physiol. 2006; 101(4):1136-1148
48. Welle S, Brooks AI, Delehanty JM, Needler N, Thornton CA. Gene expression profile of aging in human muscle. Physiol Genomics. 2003;14(2):149-159
49. Jozsi AC, Dupont-Versteegden EE, Taylor-Jones JM, Evans WJ, Trappe TA, Campbell WW, Peterson CA. Aged human muscle demonstrates an altered gene expression profile consistent with an impaired response to exercise. Mech Ageing Dev. 2000;120(1-3):45-56.
50. Signorile JF, Banovac K, Gomez M, Flipse D, Caruso JF, Lowensteyn I. Increased muscle strength in paralyzed patients after spinal cord injury: Effect of beta-2 adrenergic agonist. Arch Phys Med Rehabil. 1995;76(1):55-58.
51. Spurlock DM, McDaneld TG, McIntyre LM. Changes in skeletal muscle gene expression following clenbuterol administration. BMC Genomics. 2006;7:320.
52. Whaley MH, Brubaker PH, Otto RM, Armstrong LE. ACSM's guidelines for exercise testing and prescription. 7th ed. Philadelphia (PA): Lippincott Williams & Wilkins; 2006. p. xxi, 366.
53. Shields RK, Dudley-Javoroski S, Littmann AE. Postfatigue potentiation of the paralyzed soleus muscle: Evidence for adaptation with long-term electrical stimulation training. J Appl Physiol. 2006;101(2):556-565
54. Ivey FM, Macko RF, Ryan AS, Hafer-Macko CE. Cardiovascular health and fitness after stroke. Top Stroke Rehabil. 2005;12(1):1-16.
55. Macko RF, Ivey FM, Forrester LW. Task-oriented aerobic exercise in chronic hemiparetic stroke: Training protocols and treatment effects. Top Stroke Rehabil. 2005;12(1):45-57.
56. Macko RF, Smith GV, Dobrovolny CL, Sorkin JD, Goldberg AP, Silver KH. Treadmill training improves fitness reserve in chronic stroke patients. Arch Phys Med Rehabil. 2001;82(7):879-884
57. Gerrits HL, Hopman MT, Offringa C, Engelen BG, Sargeant AJ, Jones DA, Haan A. Variability in fibre properties in paralysed human quadriceps muscles and effects of training. Pflugers Arch. 2003;445(6):734-740
58. Kjaer M, Mohr T, Biering-Sorensen F, Bangsbo J. Muscle enzyme adaptation to training and tapering-off in spinal-cord- injured humans. Eur J Appl Physiol. 2001;84(5):482-486
59. Phillips SM, Stewart BG, Mahoney DJ, Hicks AL, McCartney N, Tang JE, Wilkinson SB, Armstrong D, Tarnopolsky MA. Body-weight-support treadmill training improves blood glucose regulation in persons with incomplete spinal cord injury. J Appl Physiol. 2004;97(2):716-724
60. Stewart BG, Tarnopolsky MA, Hicks AL, McCartney N, Mahoney DJ, Staron RS, Phillips SM. Treadmill training-induced adaptations in muscle phenotype in persons with incomplete spinal cord injury. Muscle Nerve. 2004;30(1): 61-68.